Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN1A | P35498 | 6/20 | 0.56 |
| ▸ | SCN2A | Q99250 | 6/20 | 0.56 |
| ▸ | SCN3A | Q9NY46 | 6/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.48 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.48 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.48 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.48 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26807559 | 0.83 | L3MBTL1 (0.57) | KMT2AMEN1ATMALDH1A1SMN1; SMN2 | |
| SCHEMBL21705229 | 0.80 | HTR4 (0.43) | SCN1ASCN2ASCN3AKMT2AMEN1 | |
| SCHEMBL21705246 | 0.79 | HTR3A (0.59) | KMT2AMEN1 | |
| SCHEMBL1839004 | 0.77 | SCN1A (0.75) | SCN1ASCN2ASCN3AKMT2AMEN1 | |
| SCHEMBL21705308 | 0.77 | TSHR (0.42) | SCN1ASCN2ASCN3AKMT2AMEN1 | |
| SCHEMBL26809785 | 0.75 | L3MBTL1 (0.40) | KMT2AMEN1ATMALDH1A1 | |
| SCHEMBL26427856 | 0.75 | ATM (0.53) | SCN1ASCN2ASCN3AKMT2AMEN1 | |
| SCHEMBL16689994 | 0.73 | SCN1A (0.88) | SCN1ASCN2ASCN3AKMT2AMEN1 | |
| SCHEMBL1839704 | 0.73 | KMT2A (0.97) | SCN1ASCN2ASCN3AKMT2AMEN1 | |
| SCHEMBL10306613 | 0.73 | SCN1A (0.88) | SCN1ASCN2ASCN3AKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11187980-B2 | Resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2021-11-30 | — | — | US | disclosed |
| US-20200073237-A1 | RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2020-03-05 | — | — | US | disclosed |
| US-20200050105-A1 | RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2020-02-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200050105-A1 | RESIST COMPOSITION AND PATTERNING PROCESS | HNRNPU, HNRNPR, ZFR | SCN1A 4040/4885SCN2A 3509/4885SCN3A 3733/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.